Hypertrophic differentiation occurs during in vitro chondrogenesis of mesenchymal stem cells (MSCs), decreasing the quality of the cartilage construct. Previously we identified WNT pathway antagonists Dickkopf 1 homolog (DKK1) and frizzled-related protein (FRZB) as key factors in blocking hypertrophic differentiation of human MSCs (hMSCs). In this study, we investigated the role of endogenously expressed DKK1 and FRZB in chondrogenesis of hMSC and chondrocyte redifferentiation and in preventing cell hypertrophy using three relevant human cell based systems, isolated hMSCs, isolated primary human chondrocytes (hChs), and cocultures of hMSCs with hChs for which we specifically designed neutralizing nano-antibodies. We selected and tested variable domain of single chain heavy chain only antibodies (VHH) for their ability to neutralize the function of DKK1 or FRZB. In the presence of DKK1 and FRZB neutralizing VHH, glycosaminoglycan and collagen type II staining were significantly reduced in monocultured hMSCs and monocultured chondrocytes. Furthermore, in cocultures, cells in pellets showed hypertrophic differentiation. In conclusion, endogenous expression of the WNT antagonists DKK1 and FRZB is necessary for multiple steps during chondrogenesis: first DKK1 and FRZB are indispensable for the initial steps of chondrogenic differentiation of hMSCs, second they are necessary for chondrocyte redifferentiation, and finally in preventing hypertrophic differentiation of articular chondrocytes.
Get full access to this article
View all access options for this article.
References
1.
KomarekJ, ValisP, RepkoM, ChaloupkaR and KrbecM. (2010). [Treatment of deep cartilage defects of the knee with autologous chondrocyte transplantation: long-term results]. Acta Chir Orthop Traumatol Cech, 77:291–295.
2.
SchnabelM, MarlovitsS, EckhoffG, FichtelI, GotzenL, VecseiV and SchlegelJ. (2002). Dedifferentiation-associated changes in morphology and gene expression in primary human articular chondrocytes in cell culture. Osteoarthritis Cartilage, 10:62–70.
3.
MuellerMB and TuanRS. (2008). Functional characterization of hypertrophy in chondrogenesis of human mesenchymal stem cells. Arthritis Rheum, 58:1377–1388.
4.
HubkaKM, DahlinRL, MeretojaVV, KasperFK and MikosAG. (2014). Enhancing chondrogenic phenotype for cartilage tissue engineering: monoculture and co-culture of articular chondrocytes and mesenchymal stem cells. Tissue Eng Part B Rev, 20:641–654.
5.
GreenJD, TollemarV, DoughertyM, YanZ, YinL, YeJ, CollierZ, MohammedMK, HaydonRC, et al. (2015). Multifaceted signaling regulators of chondrogenesis: implications in cartilage regeneration and tissue engineering. Genes Dis, 2:307–327.
6.
FischerJ, DickhutA, RickertM and RichterW. (2010). Human articular chondrocytes secrete parathyroid hormone-related protein and inhibit hypertrophy of mesenchymal stem cells in coculture during chondrogenesis. Arthritis Rheum, 62:2696–2706.
7.
CookeME, AllonAA, ChengT, KuoAC, KimHT, VailTP, MarcucioRS, SchneiderRA, LotzJC and AllistonT. (2011). Structured three-dimensional co-culture of mesenchymal stem cells with chondrocytes promotes chondrogenic differentiation without hypertrophy. Osteoarthritis Cartilage, 19:1210–1218.
8.
BianL, ZhaiDY, MauckRL and BurdickJA. (2011). Coculture of human mesenchymal stem cells and articular chondrocytes reduces hypertrophy and enhances functional properties of engineered cartilage. Tissue Eng Part A, 17:1137–1145.
9.
YasuharaR, OhtaY, YuasaT, KondoN, HoangT, AddyaS, FortinaP, PacificiM, IwamotoM and Enomoto-IwamotoM. (2011). Roles of beta-catenin signaling in phenotypic expression and proliferation of articular cartilage superficial zone cells. Lab Invest, 91:1739–1752.
10.
ZhuM, TangD, WuQ, HaoS, ChenM, XieC, RosierRN, O'KeefeRJ, ZuscikM and ChenD. (2009). Activation of beta-catenin signaling in articular chondrocytes leads to osteoarthritis-like phenotype in adult beta-catenin conditional activation mice. J Bone Miner Res, 24:12–21.
11.
ZhuM, ChenM, ZuscikM, WuQ, WangYJ, RosierRN, O'KeefeRJ and ChenD. (2008). Inhibition of beta-catenin signaling in articular chondrocytes results in articular cartilage destruction. Arthritis Rheum, 58:2053–2064.
12.
LeijtenJC, EmonsJ, StichtC, van GoolS, DeckerE, UitterlindenA, RappoldG, HofmanA, RivadeneiraF, et al. (2012). Gremlin 1, frizzled-related protein, and Dkk-1 are key regulators of human articular cartilage homeostasis. Arthritis Rheum, 64:3302–3312.
13.
SemenovMV, TamaiK, BrottBK, KuhlM, SokolS and HeX. (2001). Head inducer Dickkopf-1 is a ligand for Wnt coreceptor LRP6. Curr Biol, 11:951–961.
14.
BaficoA, LiuG, YanivA, GazitA and AaronsonSA. (2001). Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow. Nat Cell Biol, 3:683–686.
15.
LinK, WangS, JuliusMA, KitajewskiJ, MoosMJr. and LuytenFP. (1997). The cysteine-rich frizzled domain of Frzb-1 is required and sufficient for modulation of Wnt signaling. Proc Natl Acad Sci U S A, 94:11196–11200.
16.
LeynsL, BouwmeesterT, KimSH, PiccoloS and De RobertisEM. (1997). Frzb-1 is a secreted antagonist of Wnt signaling expressed in the Spemann organizer. Cell, 88:747–756.
17.
BaficoA, GazitA, PramilaT, FinchPW, YanivA and AaronsonSA. (1999). Interaction of frizzled related protein (FRP) with Wnt ligands and the frizzled receptor suggests alternative mechanisms for FRP inhibition of Wnt signaling. J Biol Chem, 274:16180–16187.
18.
KawanoY and KyptaR. (2003). Secreted antagonists of the Wnt signalling pathway. J Cell Sci, 116:2627–2634.
19.
GregoryCA, PerryAS, ReyesE, ConleyA, GunnWG and ProckopDJ. (2005). Dkk-1-derived synthetic peptides and lithium chloride for the control and recovery of adult stem cells from bone marrow. J Biol Chem, 280:2309–2323.
20.
MaB, van BlitterswijkCA and KarperienM. (2012). A Wnt/beta-catenin negative feedback loop inhibits interleukin-1-induced matrix metalloproteinase expression in human articular chondrocytes. Arthritis Rheum, 64:2589–2600.
21.
NalessoG, SherwoodJ, BertrandJ, PapT, RamachandranM, De BariC, PitzalisC and Dell'accioF. (2011). WNT-3A modulates articular chondrocyte phenotype by activating both canonical and noncanonical pathways. J Cell Biol, 193:551–564.
22.
MaB, LeijtenJC, WuL, KipM, van BlitterswijkCA, PostJN and KarperienM. (2013). Gene expression profiling of dedifferentiated human articular chondrocytes in monolayer culture. Osteoarthritis Cartilage, 21:599–603.
23.
NarcisiR, ClearyMA, BramaPA, HoogduijnMJ, TuysuzN, Ten BergeD and van OschGJ. (2015). Long-term expansion, enhanced chondrogenic potential, and suppression of endochondral ossification of adult human MSCs via WNT signaling modulation. Stem Cell Reports, 4:459–472.
24.
LoriesRJ, PeetersJ, BakkerA, TylzanowskiP, DereseI, SchrootenJ, ThomasJT and LuytenFP. (2007). Articular cartilage and biomechanical properties of the long bones in Frzb-knockout mice. Arthritis Rheum, 56:4095–4103.
25.
PaalanenMM, EkokoskiE, El KhattabiM, TuominenRK, VerripsCT, BoonstraJ and BlanchetotC. (2011). The development of activating and inhibiting camelid VHH domains against human protein kinase C epsilon. Eur J Pharm Sci, 42:332–339.
26.
HoogenboomHR, de BruineAP, HuftonSE, HoetRM, ArendsJW and RooversRC. (1998). Antibody phage display technology and its applications. Immunotechnology, 4:1–20.
27.
RooversRC, LaeremansT, HuangL, De TaeyeS, VerkleijAJ, RevetsH, de HaardHJ and van Bergen en HenegouwenPM. (2007). Efficient inhibition of EGFR signaling and of tumour growth by antagonistic anti-EFGR Nanobodies. Cancer Immunol Immunother, 56:303–317.
28.
SaerensD, KinneJ, BosmansE, WerneryU, MuyldermansS and ConrathK. (2004). Single domain antibodies derived from dromedary lymph node and peripheral blood lymphocytes sensing conformational variants of prostate-specific antigen. J Biol Chem, 279:51965–51972.
29.
RooversRC, HenderikxP, HelfrichW, van der LindenE, ReursA, de BruineAP, ArendsJW, de LeijL and HoogenboomHR. (1998). High-affinity recombinant phage antibodies to the pan-carcinoma marker epithelial glycoprotein-2 for tumour targeting. Br J Cancer, 78:1407–1416.
30.
WesolowskiJ, AlzogarayV, ReyeltJ, UngerM, JuarezK, UrrutiaM, CauerhffA, DanquahW, RissiekB, et al. (2009). Single domain antibodies: promising experimental and therapeutic tools in infection and immunity. Med Microbiol Immunol, 198:157–174.
31.
de MarcoA. (2011). Biotechnological applications of recombinant single-domain antibody fragments. Microb Cell Fact, 10:44.
32.
van der HorstG, van der WerfSM, Farih-SipsH, van BezooijenRL, LowikCW and KarperienM. (2005). Downregulation of Wnt signaling by increased expression of Dickkopf-1 and -2 is a prerequisite for late-stage osteoblast differentiation of KS483 cells. J Bone Miner Res, 20:1867–1877.
33.
VerheesenP, RoussisA, de HaardHJ, GrootAJ, StamJC, den DunnenJT, FrantsRR, VerkleijAJ, Theo VerripsC and van der MaarelSM. (2006). Reliable and controllable antibody fragment selections from Camelid non-immune libraries for target validation. Biochim Biophys Acta, 1764:1307–1319.
34.
WuL, CaiX, DongH, JingW, HuangY, YangX, WuY and LinY. (2010). Serum regulates adipogenesis of mesenchymal stem cells via MEK/ERK-dependent PPARgamma expression and phosphorylation. J Cell Mol Med, 14:922–932.
35.
RivronNC, VrijEJ, RouwkemaJ, Le GacS, van den BergA, TruckenmullerRK and van BlitterswijkCA. (2012). Tissue deformation spatially modulates VEGF signaling and angiogenesis. Proc Natl Acad Sci U S A, 109:6886–6891.
36.
LeijtenJ, GeorgiN, Moreira TeixeiraL, van BlitterswijkCA, PostJN and KarperienM. (2014). Metabolic programming of mesenchymal stromal cells by oxygen tension directs chondrogenic cell fate. Proc Natl Acad Sci U S A, 111:13954–13959.
37.
MuyldermansS, BaralTN, RetamozzoVC, De BaetselierP, De GenstE, KinneJ, LeonhardtH, MagezS, NguyenVK, et al. (2009). Camelid immunoglobulins and nanobody technology. Vet Immunol Immunopathol, 128:178–183.
38.
HarmsenMM and De HaardHJ. (2007). Properties, production, and applications of camelid single-domain antibody fragments. Appl Microbiol Biotechnol, 77:13–22.
39.
MuyldermansS. (2013). Nanobodies: natural single-domain antibodies. Annu Rev Biochem, 82:775–797.
40.
ZuscikMJ, HiltonMJ, ZhangX, ChenD and O'KeefeRJ. (2008). Regulation of chondrogenesis and chondrocyte differentiation by stress. J Clin Invest, 118:429–438.
41.
PacificiM, GoldenEB, OshimaO, ShapiroIM, LeboyPS and AdamsSL. (1990). Hypertrophic chondrocytes. The terminal stage of differentiation in the chondrogenic cell lineage? Ann N Y Acad Sci, 599:45–57.
42.
AkiyamaH, LyonsJP, Mori-AkiyamaY, YangX, ZhangR, ZhangZ, DengJM, TaketoMM, NakamuraT, et al. (2004). Interactions between Sox9 and beta-catenin control chondrocyte differentiation. Genes Dev, 18:1072–1087.
43.
HillTP, SpaterD, TaketoMM, BirchmeierW and HartmannC. (2005). Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes. Dev Cell, 8:727–738.
44.
MicleaRL, KarperienM, BoschCA, van der HorstG, van der ValkMA, KobayashiT, KronenbergHM, RawadiG, AkcakayaP, et al. (2009). Adenomatous polyposis coli-mediated control of beta-catenin is essential for both chondrogenic and osteogenic differentiation of skeletal precursors. BMC Dev Biol, 9:26.
45.
RyuJH, KimSJ, KimSH, OhCD, HwangSG, ChunCH, OhSH, SeongJK, HuhTL and ChunJS. (2002). Regulation of the chondrocyte phenotype by beta-catenin. Development, 129:5541–5550.
46.
PacificiM, KoyamaE and IwamotoM. (2005). Mechanisms of synovial joint and articular cartilage formation: recent advances, but many lingering mysteries. Birth Defects Res C Embryo Today, 75:237–248.
47.
WuL, LeijtenJ, van BlitterswijkCA and KarperienM. (2013). Fibroblast growth factor-1 is a mesenchymal stromal cell-secreted factor stimulating proliferation of osteoarthritic chondrocytes in co-culture. Stem Cells Dev, 22:2356–2367.
48.
MackieEJ, TatarczuchL and MiramsM. (2011). The skeleton: a multi-functional complex organ: the growth plate chondrocyte and endochondral ossification. J Endocrinol, 211:109–121.
49.
PelttariK, WinterA, SteckE, GoetzkeK, HennigT, OchsBG, AignerT and RichterW. (2006). Premature induction of hypertrophy during in vitro chondrogenesis of human mesenchymal stem cells correlates with calcification and vascular invasion after ectopic transplantation in SCID mice. Arthritis Rheum, 54:3254–3266.
50.
ZenmyoM, KomiyaS, KawabataR, SasaguriY, InoueA and MorimatsuM. (1996). Morphological and biochemical evidence for apoptosis in the terminal hypertrophic chondrocytes of the growth plate. J Pathol, 180:430–433.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
